查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肉毒桿菌毒素市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、应用、最终用户和地理位置
市场调查报告书
商品编码
1482347

肉毒桿菌毒素市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、应用、最终用户和地理位置

Botulinum Toxin Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 381 Pages | 订单完成后即时交付

价格

根据我们关于「2031 年肉毒桿菌市场预测 - 全球分析 - 按产品、应用和最终用户」的最新研究，2023 年市场价值为 73.8 亿美元，预计到 2030 年将达到 190.3 亿美元。 2031 年复合年增长率为12.6%。

肉毒桿菌毒素是由肉毒桿菌产生的神经毒素。将毒素注射到肌肉后，它会阻断向肌肉发出的神经信号，从而阻止其收缩并减少不必要的脸部线条或特征。 Botox 和 Dysport 等肉毒桿菌注射可透过放鬆引起皱纹的肌肉来改善外观。这些注射还可以治疗偏头痛、多汗症、膀胱过动症和眼部问题。

使用注射肉毒桿菌毒素、羟基磷灰石钙和透明质酸等进行脸部年轻化的非侵入性手术。这些手术的副作用最小，有助于减少橘皮组织、皱纹、脸部细纹和多余的脂肪。自然年轻化的概念是基于全面、多层、三维的方法，根据具体需求，在体积扩大、皮肤鬆弛、重塑、体积重新定位、皮肤紧緻和表面更新等程序中结合多种技术和活性成分的患者。最常用的非手术脸部手术是化学换肤、雷射换肤、软组织填充剂和肉毒桿菌。与风险较大的外科手术不同，微创手术透过更快的恢復、更少的疤痕、有限的压力和更好的患者满意度使患者受益。此外，消费者对健康、美丽和美好老化的看法不断变化，可以让全世界更好地理解和接受美学。根据国际美容整形外科学会（ISAPS）的数据，2021年非手术手术数量较2020年增加了19.9%。市场的成长。

。

按应用划分，肉毒桿菌市场洞察

肉毒桿菌毒素市场依应用分为医疗和美容。医疗领域在 2023 年占据最大的肉毒桿菌毒素市场份额，预计 2023 年至 2031 年复合年增长率最高，达 13.3%。医学部分进一步分为慢性偏头痛、肌肉痉挛、膀胱过度反应、多汗症等。美容细分市场进一步分为眉间纹/眉间纹、额头纹、鱼尾纹、方下巴/咬肌等。肉毒桿菌毒素是一种神经毒素，用于治疗和控制各种疾病，包括慢性偏头痛、痉挛性疾病、颈部肌张力失调和逼尿肌过度活跃。肉毒桿菌毒素的医学应用包括慢性偏头痛、肌肉痉挛、膀胱过度反应和多汗症。慢性偏头痛是一种严重致残的神经系统疾病，其特征是搏动性单侧或双侧头痛。它主要被描述为一种头痛，在三个月内每月至少困扰个人 15 天。肉毒桿菌注射也被发现可有效治疗脑性麻痹，使患者的严重肌肉收缩得到显着缓解。 A 型肉毒桿菌毒素治疗慢性腰痛的有效性也得到了研究。

按最终用户，基于肉毒桿菌市场的见解

从类型来看，肉毒桿菌市场分为专科和皮肤科诊所、医院和诊所等。 2023年，专科和皮肤科诊所细分市场占有最大的市场份额。有效的服务的能力服务。这些患者通常有特定的皮肤状况，需要专家评估和管理。皮肤科诊所提供的肉毒桿菌毒素治疗专为解决这些特定问题而量身定制，其定製配方旨在针对皮肤问题的根本原因。在过去的十年里，整容手术变得更加普遍。此外，微创技术的引入增加了皮肤科手术的普及。肉毒桿菌注射、透明质酸治疗、雷射除毛、非手术减脂和光子嫩肤/强烈脉衝光 (IPL) 是皮肤科诊所最常见的非手术美容手术。

国际美容整形外科学会和国家健康与护理卓越研究所是在准备肉毒毒素市场报告时提到的一些主要二手来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解
  • 市场吸引力分析

第 3 章：研究方法

第 4 章：肉毒桿菌市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链供应商名单

第 5 章：肉毒桿菌毒素市场 - 主要市场动态

  • 主要市场驱动因素
  • 主要市场限制
  • 主要市场机会
  • 未来的趋势
  • 驱动因素和限制因素的影响分析

第 6 章：肉毒桿菌毒素市场 - 全球市场分析

  • 肉毒桿菌毒素 - 全球市场概览
  • 肉毒桿菌毒素 - 全球市场与 2031 年预测

第 7 章：肉毒桿菌毒素市场 - 收入分析 - 按产品，2021-2031 年

  • 概述
  • A型肉毒桿菌毒素
  • 肉毒桿菌B

第 8 章：肉毒桿菌毒素市场 - 收入分析 - 按应用划分，2021-2031 年

  • 概述
  • 医疗的
  • 美学的

第 9 章：肉毒桿菌毒素市场 - 收入分析 - 按最终用户，2021-2031 年

  • 概述
  • 专科和皮肤科诊所
  • 医院和诊所
  • 其他的

第 10 章：肉毒桿菌毒素市场 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

註 - 将为以下提到的地区/国家提供类似的分析

  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与专注

第 13 章：肉毒桿菌毒素市场 - 主要公司概况

  • AbbVie Inc.
  • Merz Pharma
  • Aquavit Holdings
  • Evolus, Inc
  • Ipsen Pharma
  • Medytox Inc.
  • GALDERMA
  • HUGEL, Inc.
  • Revance Therapeutics Inc
  • Lanzhou Institute of Biological Products Co Ltd

第 14 章：附录

Product Code: TIPRE00027431

According to our latest study on "Botulinum Toxin Market Forecast to 2031 - Global Analysis - by Product, Application, and End User" the market was valued at US$ 7.38 billion in 2023 and is expected to reach US$ 19.03 billion by 2030. It is estimated to register a CAGR of 12.6% from 2023 to 2031.

Botulinum toxins are neurotoxins produced by bacteria named Clostridium botulinum. After the toxin is injected into a muscle, it blocks nerve signals to the muscle, thereby blocking its contraction and reducing unwanted facial lines or features. Botulinum toxin injections such as Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems.

Noninvasive procedures of facial rejuvenation using injections of botulinum toxin, calcium hydroxylapatite, and hyaluronic acid, among others. These procedures have minimal side effects and help reduce cellulite, wrinkles, facial lines, and unwanted fat. The concept of natural rejuvenation is based on a comprehensive, multilayered, three-dimensional approach that combines multiple techniques and active ingredients in procedures such as volume enlargement, skin relaxation, reshaping, volume repositioning, skin tightening, and surface renewal, depending on specific needs of patients. The most often used non-surgical face procedures are chemical peels, laser skin resurfacing, soft tissue fillers, and Botox. Unlike surgical procedures that are associated with greater risks, minimally invasive procedures benefit patients through faster recovery, lesser scarring, limited stress, and better patient satisfaction. Moreover, changing consumer views about wellness, beauty, and good aging results in a better understanding and acceptance of aesthetics worldwide. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the number of nonsurgical procedures increased by 19.9% in 2021 compared to 2020. The total number of nonsurgical procedures was 17.5 million in 2021. Thus, an upsurge in the adoption of noninvasive aesthetic procedures is driving the growth of the botulinum toxin market.

.

By Application, Botulinum Toxin Market-Based Insights

The botulinum toxin market, by application, is bifurcated into medical and aesthetic. The medical segment held the largest botulinum toxin market share in 2023 and is anticipated to register the highest CAGR of 13.3% during 2023-2031. The medical segment is further categorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. The market for the aesthetic segment is further divided into frown lines/ glabellar, forehead lines, crow's feet, square jaw/ masseter, and others. Botulinum toxin is a neurotoxin used to treat and manage various medical conditions, including chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity. Medical applications of botulinum toxin include chronic migraine, muscle spasms, overreactive bladder, and hyperhidrosis. Chronic migraine is a severely disabling neurological disorder characterized by pulsating unilateral or bilateral headaches. It is primarily described as a headache that troubles individuals for at least 15 days per month for three months. Botulinum toxin injections have also been found to be effective in treating cerebral palsy, providing patients with major relief from severe muscle contraction. Botulinum toxin A has also been studied for its effectiveness in treating chronic lower back pain.

By End User, Botulinum Toxin Market-Based Insights

In terms of type, the botulinum toxin market is categorized into specialty and dermatology clinics, hospitals and clinics, and others. The specialty and dermatology clinics segment held the largest market share in 2023. The botulinum toxin market growth in this segment is attributed to the patients' inclination toward dermatology clinics for their specialized dermatology treatment needs, and the ability of these clinics to provide rapid and effective services. These patients usually have specific skin conditions that require expert evaluation and management. Botulinum toxin treatments offered in dermatology clinics are tailored to address these specific concerns, with customized formulations designed to target the underlying causes of skin problems. Cosmetic procedures have become more widespread in the last 10 years. Moreover, the introduction of minimally invasive techniques has added to the popularity of dermatological procedures. Botulinum toxin injections, hyaluronic acid treatments, laser hair removal, nonsurgical fat reduction, and photorejuvenation/intense pulse light (IPL) have been the most common nonsurgical cosmetic procedures that are performed in dermatology clinics.

International Society of Aesthetic Plastic Surgery, and National Institute for Health and Care Excellence are a few of the major secondary sources referred to while preparing the report on the botulinum toxin market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Botulinum Toxin Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Botulinum Toxin Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Botulinum Toxin Market - Global Market Analysis

  • 6.1 Botulinum Toxin - Global Market Overview
  • 6.2 Botulinum Toxin - Global Market and Forecast to 2031

7. Botulinum Toxin Market - Revenue Analysis (USD Million) - By Product, 2021-2031

  • 7.1 Overview
  • 7.2 Botulinum Toxin A
  • 7.3 Botulinum Toxin B

8. Botulinum Toxin Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 8.1 Overview
  • 8.2 Medical
    • 8.2.1 Chronic Migraine
    • 8.2.2 Muscle Spasm
    • 8.2.3 Over Reactive Bladder
    • 8.2.4 Hyperhidrosis
    • 8.2.5 Others
  • 8.3 Aesthetic
    • 8.3.1 Crow's Feet
    • 8.3.2 Forehead Lines
    • 8.3.3 Frown Lines/ Glabellar
    • 8.3.4 Square Jaw/ Masseter
    • 8.3.5 Others

9. Botulinum Toxin Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 9.1 Overview
  • 9.2 Specialty and Dermatology Clinics
  • 9.3 Hospitals and Clinics
  • 9.4 Others

10. Botulinum Toxin Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Botulinum Toxin Market Overview
    • 10.1.2 North America Botulinum Toxin Market Revenue and Forecasts to 2031
    • 10.1.3 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Product
    • 10.1.4 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Application
    • 10.1.5 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Botulinum Toxin Market
        • 10.1.6.1.1 United States Botulinum Toxin Market, by Product
        • 10.1.6.1.2 United States Botulinum Toxin Market, by Application
        • 10.1.6.1.3 United States Botulinum Toxin Market, by End User
      • 10.1.6.2 Canada Botulinum Toxin Market
        • 10.1.6.2.1 Canada Botulinum Toxin Market, by Product
        • 10.1.6.2.2 Canada Botulinum Toxin Market, by Application
        • 10.1.6.2.3 Canada Botulinum Toxin Market, by End User
      • 10.1.6.3 Mexico Botulinum Toxin Market
        • 10.1.6.3.1 Mexico Botulinum Toxin Market, by Product
        • 10.1.6.3.2 Mexico Botulinum Toxin Market, by Application
        • 10.1.6.3.3 Mexico Botulinum Toxin Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Botulinum Toxin Market - Key Company Profiles

  • 13.1 AbbVie Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 13.2 Merz Pharma
  • 13.3 Aquavit Holdings
  • 13.4 Evolus, Inc
  • 13.5 Ipsen Pharma
  • 13.6 Medytox Inc.
  • 13.7 GALDERMA
  • 13.8 HUGEL, Inc.
  • 13.9 Revance Therapeutics Inc
  • 13.10 Lanzhou Institute of Biological Products Co Ltd

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud

List Of Tables

  • Table 1.Botulinum Toxin Market Segmentation27
  • Table 2.Nonsurgical Procedures, by Country, 202134
  • Table 3.Global Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical44
  • Table 4.Global Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic45
  • Table 5.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product52
  • Table 6.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application52
  • Table 7.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical52
  • Table 8.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic53
  • Table 9.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User53
  • Table 10.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product55
  • Table 11.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application55
  • Table 12.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical56
  • Table 13.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic56
  • Table 14.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User56
  • Table 15.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product57
  • Table 16.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application58
  • Table 17.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical58
  • Table 18.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic58
  • Table 19.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User59
  • Table 20.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product60
  • Table 21.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application61
  • Table 22.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical61
  • Table 23.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic61
  • Table 24.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User62
  • Table 25.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product65
  • Table 26.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application65
  • Table 27.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical65
  • Table 28.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic66
  • Table 29.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User66
  • Table 30.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product68
  • Table 31.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application68
  • Table 32.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical69
  • Table 33.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic69
  • Table 34.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User70
  • Table 35.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product72
  • Table 36.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application72
  • Table 37.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical72
  • Table 38.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic73
  • Table 39.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User73
  • Table 40.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product74
  • Table 41.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application75
  • Table 42.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical75
  • Table 43.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic75
  • Table 44.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User76
  • Table 45.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product77
  • Table 46.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application78
  • Table 47.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical78
  • Table 48.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic78
  • Table 49.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User79
  • Table 50.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product80
  • Table 51.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application81
  • Table 52.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical81
  • Table 53.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic81
  • Table 54.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User82
  • Table 55.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product83
  • Table 56.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application84
  • Table 57.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical84
  • Table 58.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic85
  • Table 59.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User85
  • Table 60.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product88
  • Table 61.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application88
  • Table 62.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical88
  • Table 63.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic89
  • Table 64.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User89
  • Table 65.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product91
  • Table 66.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application91
  • Table 67.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical92
  • Table 68.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic92
  • Table 69.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User93
  • Table 70.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product95
  • Table 71.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application95
  • Table 72.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical95
  • Table 73.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic96
  • Table 74.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User96
  • Table 75.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product97
  • Table 76.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application98
  • Table 77.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical98
  • Table 78.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic98
  • Table 79.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User99
  • Table 80.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product100
  • Table 81.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application100
  • Table 82.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical101
  • Table 83.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic101
  • Table 84.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User102
  • Table 85.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product103
  • Table 86.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application104
  • Table 87.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical104
  • Table 88.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic104
  • Table 89.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User105
  • Table 90.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product106
  • Table 91.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application107
  • Table 92.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical107
  • Table 93.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic107
  • Table 94.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User108
  • Table 95.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product110
  • Table 96.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application110
  • Table 97.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical111
  • Table 98.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic111
  • Table 99.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User112
  • Table 100.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product113
  • Table 101.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application114
  • Table 102.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical114
  • Table 103.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic114
  • Table 104.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User115
  • Table 105.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product116
  • Table 106.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application117
  • Table 107.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical117
  • Table 108.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic118
  • Table 109.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User118
  • Table 110.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product119
  • Table 111.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application120
  • Table 112.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical120
  • Table 113.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic120
  • Table 114.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User121
  • Table 115.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product123
  • Table 116.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application123
  • Table 117.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical123
  • Table 118.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic124
  • Table 119.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User124
  • Table 120.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product126
  • Table 121.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application126
  • Table 122.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical127
  • Table 123.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic127
  • Table 124.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User128
  • Table 125.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Country128
  • Table 126.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product130
  • Table 127.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application130
  • Table 128.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical130
  • Table 129.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic131
  • Table 130.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User131
  • Table 131.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product132
  • Table 132.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application133
  • Table 133.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical133
  • Table 134.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic133
  • Table 135.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User134
  • Table 136.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product135
  • Table 137.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application136
  • Table 138.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical136
  • Table 139.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic137
  • Table 140.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User137
  • Table 141.Recent Inorganic Growth Strategies in the Medical Ultrasound Flow Meter Market139
  • Table 142.Recent Organic Growth Strategies in the Medical Ultrasound Flow Meter Market139
  • Table 143.Glossary of Terms173

List Of Figures

  • Figure 1.Botulinum Toxin Market Segmentation, by Geography27
  • Figure 2.PEST Analysis32
  • Figure 3.Impact Analysis of Drivers and Restraints36
  • Figure 4.Botulinum Toxin Market Revenue (US$ Million), 2023-203137
  • Figure 5.Global Botulinum Toxin Market, By Geography Forecast Analysis, 2023 & 203138
  • Figure 6.Botulinum Toxin Market Share (%) - by Product (2023 and 2031)39
  • Figure 7.Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)40
  • Figure 8.Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)41
  • Figure 9.Botulinum Toxin Market Share (%) - by Application (2023 and 2031)42
  • Figure 10.Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)43
  • Figure 11.Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)44
  • Figure 12.Botulinum Toxin Market Share (%) - by End User (2023 and 2031)46
  • Figure 13.Speciality and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)47
  • Figure 14.Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)48
  • Figure 15.Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)49
  • Figure 16.North America: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)50
  • Figure 17.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)51
  • Figure 18.North America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)54
  • Figure 19.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)55
  • Figure 20.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)57
  • Figure 21.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)60
  • Figure 22.Europe: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)63
  • Figure 23.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)64
  • Figure 24.Europe: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)67
  • Figure 25.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)68
  • Figure 26.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)71
  • Figure 27.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)74
  • Figure 28.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)77
  • Figure 29.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)80
  • Figure 30.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)83
  • Figure 31.Asia Pacific: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)86
  • Figure 32.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)87
  • Figure 33.Asia Pacific: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)90
  • Figure 34.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)91
  • Figure 35.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)94
  • Figure 36.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)97
  • Figure 37.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)100
  • Figure 38.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)103
  • Figure 39.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)106
  • Figure 40.Middle East and Africa: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)109
  • Figure 41.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)110
  • Figure 42.Middle East and Africa: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)112
  • Figure 43.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)113
  • Figure 44.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)116
  • Figure 45.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)119
  • Figure 46.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)122
  • Figure 47.South and Central America: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)125
  • Figure 48.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)126
  • Figure 49.South and Central America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)128
  • Figure 50.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)129
  • Figure 51.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)132
  • Figure 52.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)135
  • Figure 53.Growth Strategies in the Medical Ultrasound Flow Meter Market138